首药控股9月25日获融资买入626.59万元，融资余额2.92亿元

Group 1 - On September 25, Shouyao Holdings experienced a decline of 1.22% with a transaction volume of 98.81 million yuan [1] - The financing data indicates that on the same day, Shouyao Holdings had a financing purchase amount of 6.27 million yuan and a financing repayment of 14.44 million yuan, resulting in a net financing outflow of 8.17 million yuan [1] - As of September 25, the total balance of margin trading for Shouyao Holdings was 292 million yuan, accounting for 9.57% of its circulating market value, which is above the 90th percentile level over the past year [1] Group 2 - As of June 30, the number of shareholders of Shouyao Holdings increased by 5.33% to 4,526, while the average circulating shares per person decreased by 5.06% to 14,141 shares [2] - For the first half of 2025, Shouyao Holdings reported an operating income of 2 million yuan, a year-on-year decrease of 47.37%, and a net profit attributable to shareholders of -104 million yuan, a decrease of 1.48% year-on-year [2] - Among institutional holdings, as of June 30, 2025, Penghua Medical Technology Stock A was the largest circulating shareholder with 5.41 million shares, unchanged from the previous period, while China Europe Medical Health Mixed A entered as the tenth largest shareholder with 1.17 million shares [2]